Background-Genetic studies demonstrated the presence of risk alleles in the genes ANRIL and CAMTA1/VAMP3 that are shared between coronary artery disease (CAD) and periodontitis. We aimed to identify further shared genetic risk factors to better understand conjoint disease mechanisms. Methods and Results-In-depth genotyping of 46 published CAD risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (AgP) with the Illumina Immunochip (600 German AgP cases, 1448 controls) and the Affymetrix 500K array set (283 German AgP cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with AgP for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10 −5 ; odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls). Subsequent combined analyses of several genome-wide data sets of CAD and AgP suggested TGFBRAP1 to be associated with AgP (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and CAD (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls). The study further provides evidence that in addition to PLG, the currently known shared susceptibility loci of CAD and periodontitis, ANRIL and CAMTA1/VAMP3, are subjected to transforming growth factor-β regulation. Conclusions-PLG is the third replicated shared genetic risk factor of atherosclerosis and periodontitis. All known shared risk genes of CAD and periodontitis are members of transforming growth factor-β signaling.
P eriodontitis is a chronic inflammatory disease of the oral cavity. The inflammation is elicited by the oral microbial biofilm that leads to gingival bleeding, pocket formation, alveolar bone loss, and eventually tooth loss as final outcome. 1 Periodontitis affects human populations worldwide at prevalence rates of 11% for the severe forms. 2 It is largely classified into the subforms chronic periodontitis (CP) and aggressive periodontitis (AgP). Whereas chronic periodontitis is mostly observed in adults and is characterized by a slow progress of the disease, AgP is the most early-onset and most extreme phenotype and found in young individuals aged <35 years. AgP is diagnosed based on rapid destruction of the alveolar bone and is comparatively rare in the general population with prevalence rates ≈0.1%. Shared with coronary artery disease (CAD), smoking, obesity, and mellitus diabetes contribute strongly to periodontitis [3] [4] [5] and both diseases are characterized by chronic inflammation. 6 Likewise, epidemiological studies demonstrated an association between the presence of CAD and periodontitis, 7 which is dependent on the severity of periodontal disease. 8 We previously showed that CAD and periodontitis are genetically related by ≥2 genetic susceptibility loci, the long noncoding antisense RNA (lncRNA) ANRIL (CDKN2BAS) at chromosome 9p21.3 9,10 and a conserved noncoding element within CAMTA1 upstream of VAMP3. 11 Molecular biological data placed ANRIL and VAMP3 into a regulatory network that integrates glucose and fatty acid metabolism with immune response, 11, 12 providing evidence for a mechanistic link between CAD, periodontitis, obesity, and inflammation. The impairment of these pathways by genetic factors may be a common pathogenic denominator of CAD and periodontitis.
Clinical Perspective on p 167
In the present study, we aimed to identify further putatively shared genetic risk factors of CAD and periodontitis to better understand the common genetic architecture of these diseases. In the first stage, we genotyped 46 CAD risk loci, which gave published evidence for genome-wide association with CAD. 13 These chromosomal regions were genotyped on the Illumina Immunochip 14 and the Affymetrix 500K Genotyping Array Set 15 using cases of AgP. For AgP it is thought that smoking, obesity, diabetes mellitus, and age have a minor role in disease development and patient samples are considered enriched with genetic risk factors that are located in genes involved in the pathogenesis of periodontitis.
In a second stage of this study, we combined several genome-wide data sets of CAD and AgP from Germany and the UK and propose a significant association within TGFBRAP1 for replication in future enlarged case-control samples of AgP.
Materials and Methods

Study Population
Details on the study populations are given in Table 1, in the Data  Supplement, and in the Tables I to III in the Data Supplement. Written informed consent was obtained from all participants. The recruitment and experimental protocols were approved by the institutional ethics review board and data protection authorities.
Genotyping
Immunochips were genotyped and analyzed as described in Ref. 16 and Affymetrix 500K arrays as described in Refs. 15, 17, and 18 . We included all single-nucleotide polymorphisms (SNPs) with a minor allele frequency (MAF) ≥5% and at a Hardy-Weinberg equilibrium for controls >5%, and with a call rate of >95%. SNP rs1981458 and rs17514846 (FURIN), rs4252120 (PLASMINOGEN) and rs2679895 (TGFBRAP1) were also genotyped on 384-well plates using TaqMan assays hCV11947689, hCV1244341, hCV11225947, and hCV27295110, respectively (Applied Biosystems) as described. 10
Analysis of Candidate Genes
Twenty-seven chromosomal regions, which gave published evidence of genome-wide association with CAD, were genotyped using the Immunochip (Illumina) in 600 German AgP cases and 1443 population representative German controls (Table 1) . 13 In addition, 18 further CAD risk loci of genome-wide significance were genotyped using the Affymetrix 500K Arrays set with 283 German AgP cases and 979 German controls. 15 See Tables IV and V in the Data Supplement for gene names, SNPs, genotypes, and association statistics of the associated genetic regions. Potential associations that were observed for genotype data of the immunochip were validated in silico in an independent case-control panel of 159 Dutch AgP cases and 679 population representative Dutch controls as described in 16 . Potential associations that were observed for genotype data of the 500K array genome-wide association study (GWAS) data were replicated using a panel of 424 German AgP cases and 3628 German controls and validated using 159 Dutch AgP cases and 352 periodontal healthy Dutch controls, as described in Table 1 .
Statistical Analysis
SNP imputation was performed in silico with the BEAGLE v.3.1.141 software package 19 and HapMap3 reference haplotypes from the Central Europeans of Utah (CEU) cohorts 20 to predict missing autosomal genotypes in silico. We subsequently analyzed only those SNPs that could be imputed with moderate confidence (r 2 >0.3) and had a minor allele frequency >1% in cases or in controls as previously described. 21 Genotypes were analyzed using the software PLINK v2. 22 Significance of association was assessed using χ 2 tests. Power calculations were performed using PS Power and Sample Size Calculations software. 23 Linkage disequilibrium measures were calculated with Haploview 4.1. 24 Logistic regression analysis was performed to adjust for possible confounding of the covariates smoking and sex in the R statistical environment. 25 For the regression analyses, smoking was coded as a binary variable according to whether a patient or control person had ever smoked. The genetic models considered were (1) an allelic model (genotypes aa, aA, and AA coded as 0, 1, and 2, respectively), (2) a dominant model (genotypes coded as 0, 1, and 1), and (3) a recessive model (genotypes coded as 0, 0, and 1). Thus, each logistic model included 3 independent variables: 2 binary covariates (sex and smoking), plus the genetic variable that was either binary (dominant or recessive genetic model) or considered continuous (allelic model). The dependent variable was always the case/control status, coded as 1 or 0, respectively.
Details on the cutoff criteria for the selection of SNPs to be taken into replication and the statistical analyses and imputation methods are described in the Data Supplement. 
Quantitative Real-Time Polymerase Chain Reaction
Cell Culture Conditions and Transforming Growth Factor-β Stimulation
Human gingival fibroblastic primary cells were derived from 3 different individuals during dental surgery. The cells of each donor were cultured in DMEM containing 1% penicillin/streptomycin and 10% heat inactivated fetal bovine serum. For each of the 3 different donors, 6 cell cultures were grown independently as biological replicates. After reaching 50% to 60% confluence, the medium of 3 cultures of each donor was replaced by fresh medium supplemented with 20 ng/mL transforming growth factor (TGF)-β for 48 hours. Three cultures of each donor continued to grow for 48 hours in replaced fresh medium that lacked the TGF-β supplement. For each biological replicate, the quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was performed in triplicates. For each donor, the mean for 3 replicates was calculated and standard 1-and 2-tailed t tests were performed. For ANRIL, C11ORF10, and VAMP3, where the effect directions were unknown, 2-tailed tests were performed. For ADIPOR1 and CDKN2B, where the effect directions after TGF-β stimulation were known from literature, a 1-tailed test was performed.
Results
Candidate Gene Association Study of Known CAD Risk Loci in AgP
Immunochip
In an explorative step of the first stage of this study, 27 established CAD risk loci of genome-wide significance were genotyped with the Immunochip. Two loci, ANRIL and FURIN, suggested association with periodontitis and fulfilled the preassigned significant threshold of P<6×10 −3 ( Table VI in the  Data Supplement; Table 2 ). The associations of ANRIL with AgP were in accordance with our previous studies. 9, 10 To show the independence of this association from established covariates, we adjusted rs1981458 for smoking and sex by logistic regression analysis. Because data on smoking were not available for 977 of the popgen PopCon control sample, we excluded these controls from the analysis. To keep sufficient statistical power (SP) for analysis of this low frequency variant, we added another 449 German blood donors (BSP; sample of Blood donors Special Phenotyped) from the biobank popgen and additional 3028 population representative German controls from the biobank KORA (Kooperative Gesundheitsforschung in der Region Augsburg) , for which data on smoking and sex were available. Before and after adjustment, this association remained significant ( Table 2) . SNP rs1981458 is located 55 bp downstream of the common GWAS lead SNP rs17514846 (MAF=47%; HapMap CEU) and is not associated with CAD in the CARDIoGRAMplusC4D
Consortium, encompassing >63 000 CAD cases and >130 000 controls. 13 rs17514846 was not included on the Immunochip. To test whether rs17514846 was also associated with AgP, we genotyped the 600 German AgP cases, which were also used for the immunochip and 4179 German healthy controls from the biobanks popgen and KORA ( Table 1 ; Table I in the Data Supplement). The association of rs17514846 was not significant here.
Affymetrix 500K
Genetic risk loci of CAD 13 that were represented on the Immunochip by ≤2 SNPs were analyzed using Affymetrix 500K arrays (Table V in the Data Supplement). Of those 28 loci, only associations within the gene PLG fulfilled the preassigned selection criteria. The best association signals were shown by PLG SNP rs4252135 (MAF=28.3%, HapMap CEU) and the PLG GWAS lead SNP of CAD, rs4252120 ( Table VII in the Data Supplement). After covariate adjustment for sex and smoking, the association of rs4252120 with AgP was significant with P allelic =0.00019 (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.20-1.78; Table 2 ). In a further sample of 424 less severe German AgP cases and 3682 controls, this association slightly missed significance (Table 1) . After adjustment for the covariates smoking and sex, the association was nominally significant under the dominant genetic model but not under the allelic model (Table 2 ). To increase the SP, both German samples were pooled (n=706 cases, 4957 controls). After adjustment for sex and smoking, the association of rs4252120 was significant with P=0.00071 and a genetic effect of OR of 1.25 and 95% CI of 1.1 to 1.4. We validated the association in the smaller Dutch AgP panel of high severity and found the same genetic effect direction (Table 2) . Next, to increase the SP, the German and Dutch samples were pooled (865 cases, 5309 controls) and adjusted for sex and smoking. The association became more significant with P allelic =5.9×10 −5 ( Table 2 ).
Combined GWAS Analysis of CAD and AgP
In the second stage of this study, SNPs that suggested association with CAD in imputed genotypes of GWAS data of the German Myocard Infarct Family Study (GerMIFS)-II were tested if they showed a similar level of significance in imputed genotypes of the GWAS on AgP. A total of 30 383 SNPs showed a P value of <0.05 in the GerMIF-II GWAS and 99 154 SNPs showed a P value of <0.05 in the AgP GWAS. Of these SNPs, 1182 SNPs were shared between both GWAS (Figure 1 ). Next, these SNPs were tested for association in a second imputed GWAS of CAD, the GerMIFS-I. At the same significance threshold, 128 SNPs showed nominal association. To further reduce the number of suggestive SNP associations, we strengthened the selection criteria. SNPs were selected, which showed a genetic effect in the same direction between the 2 CAD GWAS samples at a level of significance of P<0.01, and additionally SNPs, which showed a level of significance at a P<0.01 between the replication panel Ger-MIFS-I and the AgP GWAS sample, regardless of the effect direction (Figure 1 ). Twenty-one SNPs fulfilled these selection criteria ( Table VIII in the Data Supplement). These associations were subsequently replicated in the Wellcome Trust Case-Control Consortium CAD GWAS sample ( Table VIII in the Data Supplement). Five SNPs were located within ANRIL and 2 within TGFBRAP1 (Table 3 ). Whereas the shared association of ANRIL with AgP and CAD had repeatedly been observed by us and others, 9, 10, 16, 26 an association of TGFBRAP1 with CAD or periodontitis has not been reported previously. The ORs of the 2 TGFBRAP1-associated SNPs rs920217 and rs2679895 were identical in the 3 CAD samples (OR<0.9), which was opposite to the genetic effect in the AgP sample ( Table 3 ). The MAFs of both SNPs were similar in all CAD and AgP control samples. After adjustment of rs2679895 for the covariates smoking and sex, the effect of the rare allele of rs2679895 remained significantly associated with AgP (P allelic =0.0169; OR, 1.33; 95% CI, 1.05-1.68; Table 4 ).
To localize the association with TGFBRAP1 more precisely, all SNPs that were represented on the Affymetrix 500K arrays were tested for association with the CAD-Wellcome Trust Case-Control Consortium sample and the AgP GWAS sample (28 SNPs; Figure 2 ). Notably, a GWAS on progression of AIDS (Acquired Immune Deficiency Syndrome) reported an association with rs1020064, which was not genotyped in our samples. This SNP is located ≈1000 bp upstream of rs2576742 (Figure 2 ), 27 which was genotyped in our samples. SNP rs2576742 showed a similar level of association as rs2679895 (CAD-Wellcome Trust Case-Control Consortium: P=0.0056; OR, 0.87 [95% CI, 0.79-0.96] and AgP: P=0.0041; OR, 1.36 [95% CI, 1.10-1.68]). Analysis of the linkage disequilibrium structure of rs2679895, rs2576742, and the AIDSassociated SNP rs1020064 in a sample of German population representative controls (n=211), for which genotypes of these 3 SNPs were available, showed complete linkage (r 2 >0.98; 
Associations of TGFBRAP1 SNP rs2679895 With AgP in Samples of Different Geographical and Ethnical Background
We replicated the association of rs2679895 with AgP in 427 German AgP cases of a less severe phenotype (Table 1 ; Table III in the Data Supplement). Because the KORA control sample was part of the GerMIF-I and II studies and the popgen controls were part of the 500K Array GWAS on AgP, we used an independent sample of population representative German controls from the Metabolic Intervention Cohort Kiel (n=1292) and additional 222 periodontitis-free controls.
In the replication, rs2679895 showed similar association with AgP as was observed in the first German AgP sample ( Table 5 and see Table 6 for allele frequencies and genotypes). Because the Metabolic Intervention Cohort Kiel control sample was selected for diabetes mellitus-free men, adjustment for potential sex effects would have introduced a bias. Therefore, we adjusted for smoking only. The association remained significant (Table 4 ). To increase the SP, we pooled all German AgP cases and controls and adjusted for smoking. After adjustment of this largest sample, the allelic model showed an association with P=0.0016; OR, 1.27 (95% CI; 1.09-1.47; Table 4 ). We tested the association of rs2679895 with the smaller Dutch AgP sample ( Table III in the Data Supplement). In this sample, SNP rs2679895 was significant ( Table 5 ), but with a reversed OR compared with the discovery sample, also after adjustment for smoking and sex (Table 4 ).
Finally, we tested the association of SNP rs2679895 in a Turkish AgP sample (91 cases, 75 healthy controls; Table 4 ). Here, the association was significant, also with a reversed OR compared with the German case-control samples ( Table 4 ).
Shared Risk Loci of CAD and Periodontitis Are Regulated by TGF-β
TGFBRAP1 associates with the TGFBR complex 28 and was reported to act as an inhibitor of TGF-β signaling. 29 PLG was reported to activate TGF-β signalling 30, 31 and FURIN was also shown to be regulated by TGF-β. 32 Recently, we showed that ANRIL regulates the distant genes ADIPOR1, VAMP3, and C11ORF10 and an earlier study demonstrated that the expression of ADIPOR1 was negatively regulated by TGFβ. 33 This indicated that genes that are related to the disease pathogenesis of both CAD and AgP may act together in the same biological pathway. We tested if, in addition to PLG, TGFBRAP1, FURIN, and ADIPOR1 and also the expression of ANRIL, VAMP3, and C11ORF10 were regulated by TGF-β signaling. After TGF-β stimulation of human gingival fibroblasts, the transcriptional isoform of ANRIL that was previously shown to be positively correlated with ADIPOR1, VAMP3, and C11OF10 expression 11 was significantly reduced (P=0.0209). VAMP3 expression was also significantly reduced (P=0.0023), whereas the expression of C11ORF10 did not significantly change before and after 48 hours of TGF-β stimulation ( Figure 3 ).
Discussion
In the past, various risk alleles of ANRIL gave repeated evidence for association with CAD as well as with periodontitis. 9, 10, 18, [34] [35] [36] [37] In both parts of the current study, the candidate gene and joint GWAS analyses, we identified several variants within the coding region of ANRIL as risk factors shared between both diseases, showing the power of both approaches. We identified the CAD GWAS lead SNP rs4252120, located within the coding region of PLG, to be associated with AgP, replicated this association, and demonstrated independence of the genetic effect from the confounding factors smoking and sex. In the context of this study, it is of interest that the PLGplasmin system has an important function for degradation of tissue barriers and cell migration. 38 Various pathogenic bacteria were found to bind human PLG on bacterial PLG receptors, 39, 40 which turns them into proteolytic organisms, 41 for example, the common periodontal pathogen Porphyromonas gingivalis is able to activate human PLG expression and to inactivate human plasmin inhibitors, causing uncontrolled plasmin activity. 41 Along with other periodontal pathogens, P. gingivalis was also detected in thrombi at the sites of acute myocardial infarction. 42 We could not replicate the observed association of SNPs at FURIN. However, the associated rare allele of rs1981458 is a less frequent variant with MAF=10% and the Dutch replication panel lacked SP to reject or accept the null-hypothesis of no association. Yet, the function of FURIN makes it an interesting candidate for future research into putatively shared disease mechanisms, because FURIN, similar to PLG, is required for many pathogens to become fully pathogenic, as previously reviewed. 43 In the second stage of this study, we found an association of SNP rs2679895 within TGFBRAP1 in 3 independent CAD case-control samples and 4 independent AgP samples and demonstrated independence of the genetic effect from the confounding factors smoking and sex. In all CAD samples, the genetic effect of the association was in the same direction but in opposite direction to the 2 large German AgP samples. Similarly, the genetic effect of rs2679895 was in opposite direction in the Dutch-Irish AgP and Turkish AgP compared with the German AgP samples. Between the different control groups, the MAFs were similar, indicating that the observed effect was transmitted by the cases. We did not identify a putative causative disease associated variant at this genetic locus. It is possible that the opposite genetic effects observed in the German compared with the Dutch and Turkish AgP samples could be because of different linkage disequilibrium structures between these samples, which have different geographical and historical as well as ethnical background, respectively. Variants with both the same and opposite effects in the same pairs of different diseases have been reported before. 44 Replication studies in larger samples and finemapping of this genetic locus are required to fully elucidate the nature of the observed associations at TGFBRAP1. Our data suggest TGF-β signaling to have a role in the shared pathogenesis of CAD and periodontitis. This is in accordance with various studies that indicate that TGF-β signaling may represent a common site of intersection between the various downstream pathologies of obesity-induced complications 37 that comprise CAD and periodontitis. Interestingly, the identification of the adipokine plasminogen activator inhibitor-1, an inhibitor of the PLGplasmin system, to be strongly upregulated in visceral adipose depots in obesity also suggests a link of the PLG-plasmin system and obesity.
In conclusion, we give evidence that PLG is a shared genetic susceptibility factor of CAD and AgP. We further propose FURIN and TGFBRAP1 as good candidates for future replication studies in larger samples. The current study emphasizes the role of TGF-β signaling in the shared pathogenesis of CAD and periodontitis.
